MARÍA JESÚS
OSET GASQUE
Catedrática de universidad
Consejo Superior de Investigaciones Científicas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Consejo Superior de Investigaciones Científicas (11)
2023
-
Neuroprotective and Antioxidant Properties of CholesteroNitrone ChN2 and QuinolylNitrone QN23 in an Experimental Model of Cerebral Ischemia: Involvement of Necrotic and Apoptotic Cell Death
Antioxidants, Vol. 12, Núm. 7
-
Neuroprotective and antioxidant properties of new quinolylnitrones in in vitro and in vivo cerebral ischemia models
Scientific Reports, Vol. 13, Núm. 1
2022
-
Nucleobase-Derived Nitrones: Synthesis and Antioxidant and Neuroprotective Activities in an In Vitro Model of Ischemia–Reperfusion
International Journal of Molecular Sciences, Vol. 23, Núm. 6
2021
-
Synthesis, Neuroprotection, and Antioxidant Activity of 1,1'-Biphenylnitrones as α-Phenyl-N-tert-butylnitrone Analogues in In Vitro Ischemia Models
Molecules (Basel, Switzerland), Vol. 26, Núm. 4
-
Use of Radical Oxygen Species Scavenger Nitrones to Treat Oxidative Stress-Mediated Hearing Loss: State of the Art and Challenges
Frontiers in Cellular Neuroscience, Vol. 15
2020
-
Homo-tris-nitrones derived from α-phenyl-n-tert-butylnitrone: Synthesis, neuroprotection and antioxidant properties
International Journal of Molecular Sciences, Vol. 21, Núm. 21, pp. 1-18
-
Neuroprotection by phytoestrogens in the model of deprivation and resupply of oxygen and glucose in vitro: The contribution of autophagy and related signaling mechanisms
Antioxidants, Vol. 9, Núm. 6, pp. 1-20
-
Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models
Scientific Reports, Vol. 10, Núm. 1
2015
-
Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's disease
Future Medicinal Chemistry, Vol. 7, Núm. 7, pp. 845-855
2014
-
Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9, 10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 74, pp. 491-501
1999
-
Mechanism by which GABA, through its GABA(A) receptor, modulates glutamate release from rat cortical neurons in culture
Neurochemistry International, Vol. 34, Núm. 2, pp. 141-148